Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 12 (RPL36AP12)

Target
RPL36AP12
Molecular classification
Other (Pseudogene)
01

Overview

RPL36AP12 refers to "ribosomal protein L36a pseudogene 12," which is one of several processed pseudogenes derived from the functional ribosomal protein L36a gene (RPL36A) in the human genome[2][3]. Pseudogenes arise from gene duplications or retrotransposition events and typically lack the ability to encode functional proteins. Like other pseudogenes, RPL36AP12 does not encode a ribosomal protein or any active protein product and is not known to have a direct role as a receptor, enzyme, transporter, or other therapeutic target[2][3]. Some pseudogenes may exert regulatory roles at the RNA level (acting as decoys or regulators of parental gene expression), but there is no specific evidence for functional impact or clinical relevance for RPL36AP12. It is not considered a therapeutic or druggable target and is mainly of genomic, not clinical, interest[2][4].

02

Mechanism of action

Not applicable; as a pseudogene, does not encode a functional protein target for drugs

03

Biological functions

Other (Pseudogene; potential non-coding RNA regulatory activities, but not direct protein-coding function)
04

Disease associations

Other (No direct evidence for specific disease role for RPL36AP12; some pseudogenes broadly can act as regulators in cancer or other diseases through RNA-mediated mechanisms, but this is not known for RPL36AP12 specifically)

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 12 (RPL36AP12).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 12 (RPL36AP12).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call